Home>News> Sanofi U.S. plant sets new bar for biologics production

Sanofi U.S. plant sets new bar for biologics production

Sanofi, which has been testing robots and new production methods, has finally pulled it all together into a near sentient manufacturing operation. Having successfully produced process qualification runs at its Framingham, Massachusetts plant, it says its next-generation biologics facility is now ready for prime time.
 
The French drugmaker says the facility, which produces drugs for its specialty care portfolio, ties its R&D operations to manufacturing using what it calls “intensified, continuous biologics production technology.”

Tags: